At the news
? NEUTRALIMPACT 3/10 144 filed Jun 26, 2026 at 16:05 ET
CEO Grant Pickering filed a Form 144 notice of intent to sell 24,237 shares of Vaxcyte (PCVX) with an approximate market value of $1.30M, alongside 2,000 additional shares from family trusts. The filing signals insider selling intent but is a routine diversification move by the CEO, not a distress signal, given the company's $8.1B market cap and strong institutional backing.
- CEO Grant Pickering filed Form 144 to sell 24,237 shares of Vaxcyte common stock, valued at approximately $1.30M based on the filing date.
- An additional 2,000 shares are being sold via family trusts (Claire Pickering 2020 Delaware Trust and Benjamin Pickering 2020 Delaware Trust), each valued at ~$52,500.
- The shares to be sold were acquired through RSU vesting (2023-2025), founder shares (2013), and prior RSU vesting (2024).
- The filing is an advance notice of intent to sell, not a completed transaction, the sale may not occur.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access